biguanides has been researched along with Erythema Multiforme in 2 studies
Biguanides: Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES.
biguanides : A class of oral hypoglycemic drugs used for diabetes mellitus or prediabetes treatment. They have a structure based on the 2-carbamimidoylguanidine skeleton.
Erythema Multiforme: A skin and mucous membrane disease characterized by an eruption of macules, papules, nodules, vesicles, and/or bullae with characteristic bull's-eye lesions usually occurring on the dorsal aspect of the hands and forearms.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gehanno, JF | 1 |
Priot, AE | 1 |
Balguerie, X | 1 |
Caillard, JF | 1 |
Almeyda, J | 1 |
Baker, H | 1 |
1 review available for biguanides and Erythema Multiforme
Article | Year |
---|---|
Drug reactions. X. Adverse cutaneous reactions to hypoglycaemic agents.
Topics: Antigens; Biguanides; Desensitization, Immunologic; Drug Eruptions; Drug Hypersensitivity; Erythema | 1970 |
1 other study available for biguanides and Erythema Multiforme
Article | Year |
---|---|
Polyhexamethylenebiguanide hydrochloride exposure and erythema multiforme in a physician.
Topics: Biguanides; Erythema Multiforme; Female; France; Humans; Middle Aged; Occupational Exposure; Physici | 2006 |